NR4A1 and breast cancer: The hormone requiring the character of hormone-receptor-positive breast cancers for female hormones (i.e., estrogen and/or progesterone) [11] has brought up the idea of hormone therapies that include using hormone-receptor modulators of which tamoxifen (TMX) is the oldest one.